Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma by Abdulamir, AS et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Immunology
Open Access Research article
Changing survival, memory cell compartment, and T-helper 
balance of lymphocytes between severe and mild asthma
AS Abdulamir*1, RR Hafidh2, F Abubakar2 and KA Abbas3
Address: 1Microbiology Research Department, University Putra Malaysia, 43400, UPM, Serdang, Malaysia, 2Institute of Bioscience, University 
Putra Malaysia, 43400, UPM, Serdang, Selangor Darul Ehsan, Malaysia and 3Faculty of Food Science and Technology, University Putra Malaysia, 
43400, UPM, Serdang, Malaysia
Email: AS Abdulamir* - ahmsah73@yahoo.com; RR Hafidh - ranria77@yahoo.com; F Abubakar - fatim@putra.upm.edu.my; 
KA Abbas - fatim@putra.upm.edu.my
* Corresponding author    
Abstract
Background: Asthma is a complicated network of inflammatory reactions. It is classified into mild,
moderate, and severe persistent asthma. The success of asthma therapy relies much on
understanding the underlying mechanisms of inflammation at each stage of asthma severity. The aim
of this study was to explore the differences in apoptotic potential, CD4/CD8 ratio, memory
compartment, and T- helper (Th) 1 and 2 profile of peripheral blood lymphocytes (PBL) in patients
with mild intermittent asthma and severe persistent asthma during exacerbation periods.
Results: Four research lines were investigated and compared among mild asthmatics, severe
asthmatics, and healthy groups by applying immunocytochemical staining of PBL. Antiapoptotic and
proapoptotic proteins with Bcl-2/Bax ratio, CD4, CD8 markers with CD4+/CD8+ ratio, CD45RO+,
CD45RA+ markers with memory/naïve ratio (CD45RO+/CD45RA+). Th2/Th1 cytokines balance
represented by IL-4/IFN-γ ratio was measured by enzyme-linked immunosorbent assay (ELISA) for
in vitro PBL cytokine synthesis. It was found that Bcl-2/Bax ratio was higher in severe than in mild
asthmatics which in turn was higher than in healthy group. And memory/naïve ratio of PBL was
higher in severe than in mild asthmatics. Moreover, memory cells, CD45RO+ and CD45RO+/
CD45RA+ ratio were correlated directly with Bcl-2/Bax, in severe and mild asthma patients. In
contrast, CD4+/CD8+ ratio was not changed significantly among healthy group, mild and severe
asthmatics. However, CD8+ cells were correlated directly with memory cells, CD45RO+, in severe
asthmatics only. Interestingly, the dominant profile of cytokines appeared to change from T helper
2 (Th2) in mild asthmatics to T helper 1 (Th1) in severe asthmatics where the lowest in vitro IL-4/
IFN-γ ratio and highest IFN-γ were found.
Conclusion: It was concluded that the underlying mechanisms of inflammation might vary greatly
with asthma stage of severity. Mild intermittent asthma is mainly Th2 allergen-oriented reaction
during exacerbations with good level of apoptosis making the inflammation as self-limiting, while in
severe persistent asthma, the inflammatory reaction mediated mainly by Th1 cytokines with
progressive loss of apoptosis leading to longer exacerbations, largely expanded memory cells,
CD45RO+, leading to persistent baseline inflammation.
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Background
Inflammation is the central feature of asthma pathogene-
sis and the core of its clinical manifestations that plays the
main role in airway obstruction and hyperresponsiveness
[1]. Asthma is a waxing and waning disease that leads to
structural changes in the airways and it is a common dis-
order in which chronic inflammation of the bronchial
tubes makes them swell and cause narrowing of the air-
ways [2]. According to the United States National Heart,
Lung and Blood Institute, asthma is classified into mild
intermittent, mild persistent, moderate persistent, and
severe persistent [3]. Apoptosis malfunctions have been
involved in the chronic status of many inflammatory dis-
eases [4] including asthma leading to long lasting
unwanted inflammation and adverse effects of immune
cells recruitment and activity [5]. It was found that there is
a significant increase in percentage of anti-apoptotic Bcl-2
protein in asthmatic patients, and a decrease in the per-
centage of pro-apoptotic Bax protein in patients com-
pared with healthy individuals [6].
The 'Th2 hypothesis for asthma' was first suggested by
Mosmann in 1989 [7], who had earlier discovered the
presence of two distinct subtypes of helper T cells in mice,
namely, T helper 1 (Th1) and T helper 2 (Th2) [8]. These
two subclasses of T helper cells differ in their production
of cytokines which cross-inhibit each other. IFN-γ ampli-
fies Th1-cytokines profile [9], therefore, IFN-γ is consid-
ered as the prototype cytokine of Th1 lymphocytes which
cross regulates IL-4, the prototype cytokine of Th2 lym-
phocytes in asthma [10]. In fact, asthma has long been
considered as a purely Th2 disease [7,8], however a report
[11] stated that both Th2 and Th1 chemokines may be
involved in allergen-induced airway inflammation. More-
over, a study [12] revealed that some of the Th1-related
chemokines were predominant during human allergic
pulmonary late-phase reaction.
Regarding CD4 and CD8 markers, the role of CD4+ T cells
in the immunopathogenesis of asthma is well docu-
mented, though little is known about the role of CD8+ T
cells. A study [13] demonstrated that allergic asthma in
children showed that CD8+ T cells might play a role in the
pathogenesis of asthma. Regarding the effector memory
cells of PBL, it has been shown that CD45RO+, may pro-
vide pro-inflammatory signals that contribute to the per-
sistent airway inflammation of asthma [14]. And it was
also showed that it is not clear whether the memory com-
partment of T cells, CD45RO+ cells, vary with the progres-
sion of asthma disease or not [13].
There is to date no or very few published studies demon-
strating the relationship of changed Th1/Th2 balance with
changes of apoptosis, changes of memory cell compart-
ment, and changes of CD4+/CD8+ ratio in peripheral
blood lymphocytes (PBL) between mild intermittent and
severe persistent asthmatic adult patients during exacerba-
tions. The previous studies either were conducted on asth-
matic children or involved only part of the research lines
implemented in this study. Hence, this study was
designed to explore the correlations and changes in Th1/
Th2 balance, represented by PBL in vitro synthesis of IL-4
and IFN-γ and their ratio, PBL CD4+/CD8+ ratio, PBL Bcl-
2/Bax ratio, and PBL memory/naïve CD45RO+/CD45RA+
ratio in healthy volunteers, mild intermittent, and severe
persistent asthmatic patients. This exploration is believed
to be essential for acquiring a better understanding for the
dynamic nature of immune reaction and inflammatory
process that take place in different types and stages of
asthma. This could help physicians employ more adjusta-
ble treatments on asthma targeting the real causative fac-
tors specifically.
Methods
Study population
Fifty two asthmatic patients were involved in this study
during the period from February 2007 to March 2008 in
Selangor, Malaysia. The age of the studied patients ranged
from 17 to 53 years, none of them was regular smoker or
has other major illnesses. Thirty six patients were selected
with mild intermittent asthma and 16 with severe persist-
ent asthma. All patients were diagnosed by a specialist of
respiratory diseases and diagnosis was confirmed by pul-
monary function tests in the central Kuala Lumpur hospi-
tal. Twenty age- and sex-matched healthy volunteers (HV)
were involved in this study, aged 23 to 55 years. HV had
no history of smoking or any medical disease, and their
chest radiograms and pulmonary function tests showed
no evidence of respiratory diseases. Five mL of blood were
withdrawn from asthmatic patients and HV for PBL isola-
tion. Blood was sampled from asthmatic patients within
the first 12 hours of asthma exacerbation. Moreover, all
involved patients were subjected to similar modes of ther-
apy to avoid discrepancies in therapy protocols and to
equalize the interfering effects of the oral or inhaled ther-
apy with the study findings. Written consents were
granted by all patients and HV for interviewing and blood
sampling. Dealing with human subjects was carried out
within the scope of Helsinki declaration of ethical princi-
ples of medical research and permission was granted from
the ethics committee of biomedical research of University
Putra Malaysia.
Antibodies
Mouse monoclonal antibodies for immunocytochemistry
(ICC) assay were derived from (Abcam plc, UK) and as
follows; anti-human CD4 antibody (B379), anti-human
CD8 (BL-Ts 8/2), anti-human CD45RO (2Q1392), anti-
human CD45RA (MEM-56), anti-human Bax (ID3), and
anti-human Bcl-2 (4D7). For ELISA, mouse monoclonalBMC Immunology 2008, 9:73 http://www.biomedcentral.com/1471-2172/9/73
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antibodies were used as follows; anti-human IL-4
(NYRhIL4) from (Abcam plc, UK) and anti-human IFN-γ
(25718) from (Sigma, USA). Abcam Biotinylated goat sec-
ondary antibodies (ab6785) were used against mouse
immunoglobulins in both ELISA and ICC assays.
Isolation of peripheral blood lymphocytes
PBL were isolated from heparinized whole blood of asth-
matic patients in order to prepare a pure population of
lymphocytes. PBL separation was done in ultraviolet
hood by implementing the gradient density sedimenta-
tion technique using Ficoll hypaque (Sigma). Diluted
blood 1:2 in RPMI 1640 media (Sigma) was added slowly
onto below Ficoll layer to create two interfacing layers. By
the effect of the centrifugal force, lymphocytes were
grouped into one web-like layer which then was with-
drawn and washed three times with phosphate buffered
saline (PBS) (Sigma). Final concentration of lymphocytes
suspension was adjusted to 1 × 106 cells/mL [15].
Immunocytochemistry for peripheral blood lymphocytes
ICC procedure was carried out according to the instruc-
tions of the manufacturer of primary and secondary anti-
bodies (Abcam) with modifications. 200 μl of 1 × 106
cells/mL of lymphocytes suspension were aliquoted into
wells of the cytospin. Cytospins were performed, 650 rpm
for 6 minutes on silane-coated slides. Slides were dried in
a desiccation chamber for overnight. Slides then were
fixed in 2% paraformaldehyde (BDH) for 20 minutes at
room temperature and washed 3 times in PBS. Slides were
incubated in 95°C preheated antigen retrieval buffer, 100
mM Tris (Sigma), 5% (w/v) urea (Merck), pH 9.5 for 10
minutes in a water bath. After 3 times PBS washing, cells
were permeabilized for 15 minutes at room temperature
in blocking buffer, 3% BSA (Merck) in PBS, plus 0.1% Tri-
ton X-100 (Sigma) followed by blocking of nonspecific
binding in blocking buffer for 1 hour at room tempera-
ture.
One hundred μl of mouse monoclonal antibodies diluted
1:50 in blocking buffer at final concentration 0.005 mg/
mL were added on ICC slides against human Bax, Bcl-2,
CD4, CD8, CD45RO, and CD45RA. Slides were incubated
overnight in a humid chamber at 4°C. Next day, slides
were rinsed gently with PBS-0.05% Tween20 (Merck) and
placed in fresh PBS-Tween bath for 1 minute. 100 μl of the
biotinylated goat anti-mouse secondary antibodies 1:400
diluted in PBS at final concentration 0.00125 mg/mL were
added and incubated in humid chamber for 1 hour at
37°C. After washing with PBS-Tween20 solution, two
drops of streptaviden-Horseradish peroxidase reagent
(Dako) was applied, slides were placed in humid chamber
and incubated for 30 minutes at 37°C. The prepared DAB-
substrate chromogen (Dako) solution was then applied
and slides were incubated in dark for 20 minutes at room
temperature. Mayer's hematoxylin stain was used as coun-
terstain, and slides were then dehydrated and mounted
with DPX mounting fluid. The immunostained cells at
moderate to intense dark brown color were considered
positive and other cells were considered negative as seen
in (Fig. 1). Under light microscope, the number of brown
stained cells out of 200 countable total cells was calcu-
The immunocytochemical staining of PBL with brown color DAB-chromogen Figure 1
The immunocytochemical staining of PBL with brown color DAB-chromogen. Black arrow refers to positive cells 
with overall DAB dark brown staining. White arrow refers to negative cells with overall blue hematoxylin counterstaining. (A) 
An example of few positively immunostained cells with Bcl-2 in HV. (B) An example of numerous positively immunostained 
cells with Bcl-2 in severe asthmatic patients. The photos were taken at magnification power of 100×.BMC Immunology 2008, 9:73 http://www.biomedcentral.com/1471-2172/9/73
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lated to measure the percentage of the positive PBL
expressing Bax, Bcl-2, CD4, CD8, CD45RO, and CD45RA.
Enzyme-linked immunosorbent assay for in vitro synthesis 
of PBL cytokines
PBL cells were incubated for 3 days at 37°C in 1.5 mL
microcentrifuge tubes containing complete RPMI-1640
medium (Sigma) with 200 U/mL penicillin G, 200 μg/mL
streptomycin, and 10% human AB serum at a concentra-
tion of 1 × 106 cells/mL. At 4th day, PBL cells were centri-
fuged at 2000 g for 5–10 minutes, and then the
supernatant was collected in a sterile tube. The collected
supernatant of the in vitro PBL culture was diluted 1:10 in
carbonate-bicarbonate coating buffer (1.59 g/L carbonate
& 2.93 g/L bicarbonate) (Merck). 50 μl/well of the super-
natant-coating buffer mixture were added in duplicates to
a sterile 96 wells microtiter plate which was incubated
overnight at 4°C. Next day, the remaining fluid was aspi-
rated and wells were washed twice with washing buffer
(PBS, 1% BSA w/v from Merck, 0.05% v/v Tween 20 from
Merck). Blocking buffer (PBS, 1% BSA w/v) was then
added for 1 hour. After a washing step, 50 μl of mouse
monoclonal antibodies diluted 1:50 in blocking buffer at
final concentration 0.002 mg/mL were added and incu-
bated for 2 hours at 37°C. After a washing step, 50 ul of
the biotinylated goat anti-mouse antibodies at final con-
centration 0.003 mg/mL were added and incubated for 1
hour at 37°C. After washing, 50 ul of streptaviden-horse-
radish peroxidase reagent (Dako) were added and incu-
bated for 30 minutes at 37°C. After washing, 50 ul of
OPD-H2O2 chromogen solution (Sigma) were added and
microtiter plate was kept in dark for 15 minutes at room
temperature. ELISA readings for optical density (OD)
were measured immediately by microtiter reader A-1764A
(Beckman) at wavelength of 492 nm [16].
Statistical analysis
The statistical analysis was preformed using software SPSS
version 10 and MS Excel 2000. After confirming the nor-
mal distribution pattern of both ICC and ELISA values by
using normal distribution tests, mean ± 2 standard error
and parametric multivariate student t-tests were used to
evaluate the significance of differences. Pearson's correla-
tion coefficient was used for correlating the level of
expression of the studied targets in the involved groups of
asthmatic patients.
Results
The immunostaining of PBL for Bax, Bcl-2, CD4, CD8, 
CD45RO, and CD45RA
The isolated PBL from mild asthmatics, severe asthmatics,
and HV groups were examined by immunocytochemistry.
It was found that the mean percentage of the positive PBL
for Bax was lower in severe asthmatics, 11.48 ± 9.6, than
the close figures found in both mild, 29.41 ± 7.4, and HV,
35.23 ± 7.5 (P < 0.05). In contrast, the mean percentage of
positive PBL for Bcl-2 was higher in severe asthmatics,
33.57 ± 8.4, than the close figures in both mild asthmat-
ics, 16.38 ± 5.4, and HV, 8.34 ± 4.8 (P < 0.05). Accord-
ingly, the mean Bcl-2/Bax ratio was calculated and was at
highest level in the severe asthmatic patients, 2.9 ± 1.6,
and significantly higher than in mild asthmatics, 0.55 ±
0.1, (P < 0.05) and in mild asthmatics was in turn higher
than in HV, 0.23 ± 0.11, (P < 0.05) (Fig. 2 and 3).
It was found that the mean percentage of CD4+ PBL was
not significantly different in mild asthmatics, 45.24 ± 7.5,
in HV, 41.67 ± 8.4, and in severe asthmatics, 37.54 ± 12.5
(P > 0.05). Similarly, the mean percentage of CD8+ PBL
was not significantly different in severe asthmatics, 26.62
± 8.5, mild asthmatics, 23.92 ± 6.5, and HV, 24.57 ± 5.6
(P > 0.05). Accordingly, the mean CD4+/CD8+ ratio was
not significantly different too in severe asthmatics, 1.41 ±
0.31, mild asthmatics, 1.89 ± 0.46, and 1.6 ± 0.35 (P >
0.05) (Fig. 2 and 3).
Regarding CD45RO and CD45RA markers, it was found
that the mean percentage of the memory CD45RO+ PBL
was higher in severe asthmatics, 39.46 ± 5.3 than in mild
asthmatics, 23.67 ± 4.7 and HV 24.6 ± 7.4 (P < 0.05),
while no significant difference was found for the mean
percentage of naïve CD45RA+ PBL in severe asthmatics,
67.35 ± 8.5, mild asthmatics, 70.4 ± 11.8, and HV, 71.5 ±
9.1 (P > 0.05). Accordingly, the memory/naïve CD45RO+/
CD45RA+ ratio in severe asthmatics, 0.58 ± 0.11, was
higher than that in mild asthmatics, 0.33 ± 0.12, and in
HV group, 0.34 ± 0.11 (P < 0.05) (Fig. 2 and 3).
Enzyme-linked immunosorbent assay for IL-4 and IFN-γ
The isolated PBL from severe and mild asthmatics as well
as HV group were cultured in vitro in complete RPMI
medium for 3 days and the level of the in vitro synthesis
of IL-4 and IFN-γ was measured by ELISA in terms of opti-
cal density (OD) values. It was found that the in vitro syn-
thesis of IFN-γ was increasing in parallel with disease
severity. It was found that OD level of IFN-γ in severe asth-
matics, 0.65 ± 0.1, was significantly higher than in mild
asthmatics, 0.44 ± 0.08 (P < 0.05) which in turn was
higher than in HV, 0.23 ± 0.07 (P < 0.05) (Fig. 4). On the
other hand, OD level of IL-4 was significantly highest in
mild asthmatics, 0.47 ± 0.09, in comparison with severe
asthmatics, 0.31 ± 0.06 and HV, 0.28 ± 0.05 (P < 0.05)
(Fig. 4). Accordingly, the IL-4/IFN-γ ratio was calculated
giving a clue on the polarization of the isolated PBL. The
lower IL-4/IFN-γ ratio, the more Th1 polarized PBL and
the higher IL-4/IFN-γ ratio, the more Th2 polarized PBL.
IL-4/IFN-γ ratio was remarkably lower in severe asthmat-
ics, 0.47 ± 0.09, than in HV, 1.21 ± 0.1, and mild asthmat-
ics, 1.06 ± 0.08 (P < 0.05) (Fig. 4).BMC Immunology 2008, 9:73 http://www.biomedcentral.com/1471-2172/9/73
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The mean percentages ± 2 standard errors of the ICC positively stained PBL for the studied markers in severe asthmatic  patients, mild asthmatic patients, and HV group Figure 2
The mean percentages ± 2 standard errors of the ICC positively stained PBL for the studied markers in severe 
asthmatic patients, mild asthmatic patients, and HV group. (A) Bax was significantly lower in severe asthmatics than 
other groups (B) Bcl-2 was significantly higher in severe asthmatics than other groups. (C) No significant difference in CD4 
expression among the studied groups. (D) No significant difference in CD8 expression among the studied groups. (E) CD45RO 
was significantly higher in severe asthmatics than other groups. (F) No significant difference in CD45RA expression among the 
studied groups.
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The correlations in the studied markers and cytokines
The Pearson's correlation coefficient (r) was used as a tool
to shed light on the correlating behavior of the expressed
markers and the synthesized cytokines of PBL with each
other. It was found that the PBL expression of Bax was
inversely correlated with Bcl-2, in mild asthmatics, r = -
0.65, severe asthmatics, r = -0.43 and in HV, r = -0.47
groups (P < 0.05). CD45RO+/CD45RA+ ratio was corre-
lated directly with Bcl-2/Bax ratio, r = +0.53, in severe
asthmatics only (P < 0.05). The level of CD45RO expres-
sion was positively correlated with Bcl-2 in PBL of severe
asthmatics, r = +0.74, and mild asthmatics, r = +0.63 (P <
0.05). The level of CD8 expression was positively corre-
lated with that of CD45RO, r = +0.62 in severe asthmatics
only (P < 0.05).
Discussion
In this study, ICC was used to visualize the expression of
the studied markers. Although ICC is not a sophisticated
procedure, it is considered by some reports as more sensi-
tive and specific than flow cytometry [17]. Moreover, ICC
has long been the golden standard for evaluating flow
cytometry and devoid of the flow cytometry's major draw-
back which is the lack of visual control and morphology
of the stained targets [18]. On the other hand, non-sand-
wich ELISA protocol was used in this study by coating the
The mean ratio ± 2 standard errors of Bcl-2/Bax, CD4/CD8, and CD45RO/CD45RA Figure 3
The mean ratio ± 2 standard errors of Bcl-2/Bax, CD4/CD8, and CD45RO/CD45RA. (A) BCL-2/Bax ratio was sig-
nificantly higher in severe than in mild asthmatics which in turn was higher than in HV group. (B) The difference of mean CD4+/
CD8+ ratio in severe asthmatics, mild asthmatics, and HV was statistically insignificant. (C) The mean CD45RO+/CD45RA+ 
ratio was significantly higher in severe asthmatics than other groups.
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solid phase with the supernatant of in vitro PBL culture.
Even though this method is a bit less sensitive than sand-
wich ELISA, the art showed that blocking the non-specific
epitopes of the coated antigens renders the assay more
specific than sandwich ELISA which depends on the
coated antibodies. Moreover, OD levels of ELISA were
used directly in the analysis of the results without using
calibrated concentrations because the aim of this study
was to compare the expression level of the studied targets
in the involved groups rather than measure the real con-
centrations. It was essential to use consistent protocols,
conditions, and devices for ELISA to prepare the suitable
background for a reliable comparative analysis of the tar-
get markers and cytokines.
It was found that the survival of PBL in asthmatic patients
was higher than in HV and increases with asthma severity,
represented by increasing Bcl-2/Bax ratio. The results of
this study are in agreement with other recent studies
revealed that Bcl-2 or Bcl-2/Bax ratio increase in asthmatic
lungs in comparison with normal lungs [14,19]. In
asthma, where the inflammation is the major problem,
lymphocyte persistence may play a key role in the patho-
physiology that lead to chronic persistent airway inflam-
mation [20]. Since Bcl-2 and Bax were inversely correlated
in asthmatic patients and HV group, this confirmed that
Bcl-2 protein can inhibit the expression and effect of pro-
apoptotic Bax proteins. The progressive decrease of apop-
tosis with the increase of severity, chronicity, and persist-
(A) The mean OD value ± 2 standard errors of in vitro PBL synthesis of IFN-γ increased significantly with asthma severity Figure 4
(A) The mean OD value ± 2 standard errors of in vitro PBL synthesis of IFN-γ increased significantly with 
asthma severity. (B) The mean OD value ± 2 standard errors of in vitro PBL synthesis of IL-4 was significantly highest in mild 
asthmatics than severe asthmatics and HV groups. (C) The mean ratio ± 2 standard errors of IL-4/IFN-γ was remarkably lower 
in severe asthmatics than mild asthmatics and HV groups.
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ence of asthmatic inflammation refers to the role of
increased life span of the activated PBL in the progression
of the disease.
Decreased apoptosis in PBL may explain the extensive
exacerbations but not the persistent inflammatory reac-
tions seen exclusively in severe persistent asthma. Persist-
ent inflammation needs abundant presence of readily
primed memory lymphocytes in lung and peripheral
blood [21]. Therefore, the memory/naïve ratio of PBL was
measured to investigate the changes in memory compart-
ment with asthma severity. The percentage of CD45RO+
PBL as well as memory/naïve, CD45RO+/CD45RA+, ratio
were much higher in severe asthmatics than in mild asth-
matics or in HV group. This indicated that the memory
compartment in PBL of severe asthmatic patients was
expanded significantly and this might lead to persistent
inflammatory reactions in lung with or without the pres-
ence of the specific allergen. Few studies have reported
imbalance in memory CD45RO+ cells in the peripheral
blood of patients with asthma and allergy but the results
were inconsistent [22-24]. Others revealed that an
increase in the memory cells, CD54RO+, in lung or
peripheral blood may be an evidence of chronic inflam-
mation in asthmatic children [13]. However, they found
no correlation between the severity of asthma and the
expression of the memory marker, CD45RO, on CD4+ T
cells. The correlation of CD45RO+ PBL and CD45RO+/
CD45RA+ ratio with apoptosis markers was investigated. It
was found that percentages of CD45RO+  PBL and
CD45RO+/CD45RA+ ratio were positively correlated with
Bcl-2 and Bcl-2/Bax ratio respectively in mild and severe
asthmatic patients. This is in agreement with another
study [13] that stated that effector memory T-cells,
CD45RO+, may provide pro-inflammatory signals that
contribute to the persistent airway inflammation which is
characteristic of asthma, and reduced apoptosis of these
cells may prolong their effects.
Surprisingly, there were no significant changes observed
in the expression level of CD4 and CD8 markers, nor
changes were found in CD4+/CD8+ ratio in the studied
groups of asthma and HV. This provided evidence that
asthmatic inflammation, even though severe, is not solely
triggered by CD4+ cells, as previously was believed. This
study suggests that asthmatic inflammation originates
from both CD4+ and CD8+ cells. This finding is backed up
by a previous report [25] which identified the presence of
allergen-specific CD8+ T cells. As a remarkable finding, the
percentage of CD8+ cells was positively correlated with the
percentage of memory cells, CD45RO+ PBL, in severe asth-
matics. This finding might indicate an increasing role of
the memory cells, CD8+CD45RO+ in the pathogenesis of
severe asthmatic inflammation.
Spontaneous in vitro synthesis of cytokines was pursued
in this study to avoid any induced T helper polarization.
Some reports demonstrated an increased PBL production
of IFN-γ in subjects with asthma via induced in vitro syn-
thesis [26,27] which is thought to be a biased Th1 polari-
zation as a response to the induction stimuli of in vitro
synthesis [28]. ELISA was designed to measure the level of
the in vitro synthesis of IL-4 as Th2 prototype cytokine
and IFN-γ as Th1 prototype cytokine. The in vitro synthe-
sis of IFN-γ was significantly increasing with asthma sever-
ity. It was higher in severe persistent than in mild
asthmatics and was higher in mild asthmatics than in HV
group. On the other hand, the pattern of the in vitro syn-
thesis of IL-4 was totally different. It was significantly
highest in mild asthmatics and low in both severe asth-
matics and HV group. Therefore, Th1 cytokines, which
were represented by IFN-γ, appeared to take a larger role
in asthmatic pathogenesis as disease becomes more
chronic and severe. There was a report revealed that the
frequencies of T cells producing IFN-γ, but not type 2
cytokines, increased in subjects with asthma compared
with normal subjects [29]. However, the role of IFN-γ in
causing or aggravating asthma was not proved by other
studies [30,31]. It is worth mentioning that Th2 hypothe-
sis of asthma is defined as the consequent alteration in
cytokine milieu with excess Th2 products in concert with
decreased Th1 products [32]. Therefore, it is paradoxical
to relate the increased production of IFN-γ in asthmatics
with Th2 hypothesis of asthma given the cross inhibition
between IFN-γ and Th2 cytokines [33]. Nevertheless, the
findings of this study might solve this confusion. The
inflammatory reactions in mild intermittent asthma
group were driven mainly by Th2 cytokines because of the
very high level of IL-4 and moderately low level of IFN-γ.
On the other hand, when asthma became chronically
severe, Th1 cytokines became the main player because of
the very high level of IFN-γ and low level of IL-4. Accord-
ingly, IL-4/IFN-γ, or Th2/Th1, ratio was significantly lower
in severe asthmatics than in both mild asthmatics and HV
group. Therefore, PBL of HV group expressed a balanced
Th2/Th1 profile with low level of both IL-4 and IFN-γ
cytokines. PBL of mild asthmatics expressed balanced
Th2/Th1 with mild tendency to Th2, not purely dominant
Th2 as previously thought. And PBL of severe asthmatics
expressed Th1-polarized profile with very high level of
IFN-γ and lower levels of IL-4. Actually this counteracts
partially the Th2 hypothesis of asthma that does not dis-
criminate between severe and mild asthma as different
entities.
Conclusion
Taken together, asthma is a disease of different pathoge-
netic backgrounds. The immune reactions in mild inter-
mittent asthmatics seem to be mediated mainly by Th2
cytokines, with shorter life spans of PBL due to betterBMC Immunology 2008, 9:73 http://www.biomedcentral.com/1471-2172/9/73
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functioning apoptotic pathways, with less memory cells of
PBL, and both CD4+ and CD8+ cells affect the disease
without bias to each of them. On the other hand in severe
persistent asthma, immune reactions seem to be mediated
increasingly by Th1 cytokines, with longer life span of PBL
due to progressive loss of apoptosis, with expanded com-
partment of memory cells in PBL leading to more persist-
ent inflammatory reactions, and both CD4+ and CD8+
cells seem to act together in the disease with predilection
to CD8+ type of memory cells, CD45RO+ cells. Collec-
tively, this scenario provides the bases for persistent less
allergen-dependent inflammation in severe asthmatic
patients. In respect to the current findings, it might be nec-
essary to adjust asthma therapy to the type and severity of
asthma where different mechanisms of allergic inflamma-
tion and immune responses take place.
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